APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 249 filers reported holding APELLIS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $5,706,000 | +794.8% | 150,000 | +2042.9% | 0.11% | +863.6% |
Q2 2023 | $637,700 | -87.1% | 7,000 | -90.7% | 0.01% | -89.4% |
Q1 2023 | $4,947,000 | +856.7% | 75,000 | +650.0% | 0.10% | +766.7% |
Q4 2022 | $517,100 | -95.8% | 10,000 | -94.4% | 0.01% | -95.8% |
Q3 2022 | $12,291,000 | +1147.8% | 179,958 | +256.2% | 0.29% | +860.0% |
Q1 2019 | $985,000 | – | 50,527 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Octagon Capital Advisors LP | 3,130,000 | $119,065,200 | 18.29% |
EcoR1 Capital, LLC | 10,899,859 | $414,630,636 | 13.99% |
Ally Bridge Group (NY) LLC | 181,805 | $6,915,862 | 8.12% |
Avoro Capital Advisors LLC | 11,111,111 | $422,666,662 | 6.59% |
ACUTA CAPITAL PARTNERS, LLC | 244,484 | $9,300,171 | 6.23% |
Iron Triangle Partners LP | 880,000 | $33,475,200 | 4.89% |
Cormorant Asset Management, LP | 2,000,000 | $76,080,000 | 4.44% |
Octagon Capital Advisors LP | 675,000 | $25,677,000 | 3.94% |
Logos Global Management LP | 750,000 | $28,530,000 | 3.81% |
Boxer Capital, LLC | 1,726,000 | $65,657,040 | 3.50% |